Showing results (61-70 of 649) with videos related to
Sort By:
Pageof 65
PPAR Research|July 7, 2016
PPARγ Agonists as an Anti-Inflammatory Treatment Inhibiting Rotavirus Infection of Small Intestinal VilliDory Gómez, Natalia Muñoz, Rafael Guerrero, et al.PPAR Research|January 24, 2018
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver DiseaseNan Wang, Rui Kong, Hui Luo, et al.PPAR Research|April 25, 2009
PPAR and liver injury in HIV-infected patientsMaud Lemoine, Jacqueline Capeau, Lawrence SerfatyPPAR Research|September 26, 2008
Regulation of Cell Proliferation and Differentiation by PPARbeta/deltaRolf Müller, Markus Rieck, Sabine Müller-BrüsselbachPPAR Research|August 30, 2008
PPARalpha Ligands as Antitumorigenic and Antiangiogenic AgentsAmbra Pozzi, Jorge H CapdevilaPPAR Research|March 28, 2009
Is PPARγ a prospective player in HIV-1-associated bone disease?Eoin J Cotter, Patrick W Mallon, Peter P DoranPPAR Research|July 23, 2008
PPAR Ligands as Potential Modifiers of Breast Carcinoma OutcomesAncha BaranovaPPAR Research|September 5, 2008
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical StudiesMark A Deeg, Meng H TanPPAR Research|January 30, 2007
Fine-Tuning Reception in the Bone: PPARgamma and CompanyZ Elizabeth Floyd, Sanjin Zvonic, Mark E Nuttall, et al.PPAR Research|January 30, 2007
Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-alpha (PPARalpha)Eric S Tien, Daniel B Hannon, Jerry T Thompson, et al.Pageof 65